Abbott Freestyle Libre
Abbott joins Dexcom, Glooko and Roche as a data-sharing partner for the as-yet-unlaunched device.
Also: The pharma industry continues to use digital technologies for R&D and diabetes management.
The clearance brings US readers a feature long available in Europe, and paves the way for data plays.
The new product adds night-time alarms, making the low-cost 14-day CGM more useful.
Realtime blood glucose information will allow Livongo's platform to deliver more insights, coaching to people with diabetes.